首页> 外文会议>2013 ICME International Conference on Complex Medical Engineering >Differential expression of semicrabazide-sensitive amine oxidase (SSAO) in human umbilical arterial tissue, E.coli BL21, HEK and HUAEC
【24h】

Differential expression of semicrabazide-sensitive amine oxidase (SSAO) in human umbilical arterial tissue, E.coli BL21, HEK and HUAEC

机译:半crabazide敏感胺氧化酶(SSAO)在人脐动脉组织,大肠杆菌BL21,HEK和HUAEC中的差异表达

获取原文
获取原文并翻译 | 示例

摘要

Semicarbazide-sensitive amine oxidase (SSAO) is multifunctional enzyme which is highly express in vasculature, smooth muscle and adipose tissues. Clinical and experimental studies suggest that increased activity and the catalytic product of deamination may be toxic and cause the tissue damage. Correlation between the SSAO activity and severity of different serious pathological condition such as Diabetes, Alzheimer's disease and atherosclerosis have been widely reported but pathophysiological meaning of this enzyme is not yet discovered. Therefore, research related to SSAO as therapeutic objective are becoming more important. We present liquid chromatography electrospray ionization mass spectrometry (LC-MS/MS) based comparative enzymatic activity and expression study in human umbilical tissue, universal recombinant expression system E.coli; commonly used cell line i.e., human embryonic kidney cell (HEK) and naturally SSAO expressive primary vascular cell line i.e., human umbilical arterial endothelial cell (HUAEC). Our results indicate that HEK:SSAO is best model among these while the second most abundant activity was observed in E.coli BL21:SSAO, with a rough estimation HEK:SSAO shows two to three fold higher activity than HUAEC. The concept of comparison provides new insight on this enzyme expression. Our models also open new possibilities for the evaluation of potential compounds that could modify SSAO activity for therapeutic determinations.
机译:氨基脲敏感的胺氧化酶(SSAO)是一种多功能酶,在血管,平滑肌和脂肪组织中高度表达。临床和实验研究表明,增加的活性和脱氨的催化产物可能是有毒的,并引起组织损伤。 SSAO活性与糖尿病,阿尔茨海默氏病和动脉粥样硬化等各种严重病理状况的严重程度之间的相关性已被广泛报道,但该酶的病理生理意义尚未发现。因此,与SSAO相关的研究作为治疗目标变得越来越重要。我们目前基于液相色谱电喷雾电离质谱法(LC-MS / MS)在人脐带组织,通用重组表达系统E.coli中的比较酶活性和表达研究。通常使用的细胞系,即人胚胎肾细胞(HEK)和天然表达SSAO的原代血管细胞系,即人脐动脉内皮细胞(HUAEC)。我们的结果表明,HEK:SSAO是其中最好的模型,而在大肠杆菌BL21:SSAO中观察到第二大活性,粗略估计HEK:SSAO的活性比HUAEC高出2到3倍。比较的概念为这种酶表达提供了新的见识。我们的模型还为评估可能改变SSAO活性以进行治疗性测定的潜在化合物提供了新的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号